Agyany Pharmaceuticals

Agyany Pharmaceuticals is a research-driven biotechnology company based in Hyderabad, India, specializing in the discovery and development of novel small molecule therapeutics. The company focuses on addressing unmet medical needs in oncology and metabolic diseases, utilizing an internal R&D platform to design selective inhibitors. Agyany's pipeline includes early-stage programs targeting cyclin-dependent kinases and other validated pathways in cancer and diabetes. The firm aims to advance its proprietary candidates through pre-clinical validation toward global clinical trials. By leveraging expertise in medicinal chemistry and structure-based drug design, Agyany seeks to create high-value intellectual property in the life sciences sector.